#medicalinnovation
Immunotherapy Breakthrough Gives New Hope for Colorectal Cancer Patients
Colorectal cancer is currently the third most common cancer in the world, following lung and breast cancers. In recent years, doctors and researchers have noticed a steady increase in cases across many countries, including India. Despite the rising number of diagnoses, new medical advancements are offering hope to patients. One of the most promising developments is immunotherapy, a treatment that helps the body’s immune system detect and attack cancer cells more effectively. Unlik
Immunotherapy Breakthrough Gives New Hope for Colorectal Cancer Patients
Colorectal cancer is currently the third most common cancer in the world, following lung and breast cancers. In recent years, doctors and researchers have noticed a steady increase in cases across many countries, including India. Despite the rising number of diagnoses, new medical advancements are offering hope to patients. One of the most promising developments is immunotherapy, a treatment that helps the body’s immune system detect and attack cancer cells more effectively. Unlik
China Performs First Satellite-Powered Remote Surgery
In a pioneering advancement for global healthcare, Chinese doctors have successfully conducted the world’s first satellite-powered robotic surgeries over a distance exceeding 5,000 kilometers. Utilizing the Apstar-6D satellite, the medical team led by Professor Rong Liu at the PLA General Hospital remotely operated from Lhasa on two patients in Beijing a 68-year-old with liver cancer and a 56-year-old with hepatic hemangioma. Both surgeries were complete
China Performs First Satellite-Powered Remote Surgery
In a pioneering advancement for global healthcare, Chinese doctors have successfully conducted the world’s first satellite-powered robotic surgeries over a distance exceeding 5,000 kilometers. Utilizing the Apstar-6D satellite, the medical team led by Professor Rong Liu at the PLA General Hospital remotely operated from Lhasa on two patients in Beijing a 68-year-old with liver cancer and a 56-year-old with hepatic hemangioma. Both surgeries were complete









